AICRX
Price
$37.95
Change
+$0.19 (+0.50%)
Updated
Jul 3 closing price
Net Assets
1.92B
VIVAX
Price
$70.13
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

AICRX vs VIVAX

Header iconAICRX vs VIVAX Comparison
Open Charts AICRX vs VIVAXBanner chart's image
American Century Discplnd Cor Val R
Price$37.95
Change+$0.19 (+0.50%)
VolumeN/A
Net Assets1.92B
Vanguard Value Index I
Price$70.13
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
AICRX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
AICRX vs. VIVAX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AICRX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. AICRX (1.92B). VIVAX pays higher dividends than AICRX: VIVAX (2.06) vs AICRX (0.90). AICRX was incepted earlier than VIVAX: AICRX (22 years) vs VIVAX (33 years). AICRX (1.16) is less costly to investors than VIVAX (0.17). AICRX is a more actively managed with annual turnover of: 67.00 vs. VIVAX (9.00). AICRX has a lower initial minimum investment than VIVAX: AICRX (2500) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 12.04 vs. AICRX (9.83). VIVAX return over 5 years is better than : 80.14 vs. AICRX (10.13).
AICRXVIVAXAICRX / VIVAX
Total Expense Ratio1.160.17682%
Annual Report Gross Expense Ratio1.160.17682%
Fund Existence22 years33 years-
Gain YTD4.3026.20969%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets1.92B189B1%
Annual Yield % from dividends0.902.0644%
Returns for 1 year9.8312.0482%
Returns for 3 years29.1935.1683%
Returns for 5 years10.1380.1413%
Returns for 10 years16.91115.7415%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SOL1.910.03
+1.60%
Emeren Group Ltd
CE60.880.26
+0.43%
Celanese Corp
BNL16.340.03
+0.18%
Broadstone Net Lease
BCLI1.16-0.01
-0.85%
Brainstorm Cell Therapeutics
ECX2.16-0.04
-1.82%
ECARX Holdings